# Quetiapine ameliorates sensorimotor gating, recognition memory, and neuroendocrine plasticity in chronic stress–induced female rats

**Authors:** Burcu Çevreli, Öznur Özge Özcan, Kübra Kayıkçı, Elif İrem Başıeğri

PMC · DOI: 10.1007/s11011-026-01834-8 · 2026-03-28

## TL;DR

Quetiapine helps reduce stress-related behavioral and hormonal changes in female rats exposed to chronic stress.

## Contribution

This study shows quetiapine mitigates chronic stress effects in female rats through behavioral and neuroendocrine improvements.

## Key findings

- Chronic stress reduced prepulse inhibition and recognition memory in female rats.
- Quetiapine improved sensorimotor gating and restored memory performance.
- Quetiapine partially reduced stress-induced corticosterone elevations and modulated BDNF levels.

## Abstract

Chronic stress induces sensorimotor, cognitive, and neuroendocrine alterations, particularly in females who exhibit heightened vulnerability to stress-related disorders. This study tested the hypothesis that chronic quetiapine administration during ongoing unpredictable chronic mild stress (UCMS) would attenuate stress-induced impairments in sensorimotor gating, recognition memory, and HPA-axis–related biochemical markers in female rats. Adult female Wistar rats were exposed to a 9-week UCMS paradigm, with quetiapine (10 mg/kg/day, i.p.) administered during the final 3 weeks. Behavioral outcomes were assessed using prepulse inhibition (PPI), startle reactivity, and the Novel Object Recognition (NOR) test. Serum and hippocampal corticosterone and BDNF levels were quantified by ELISA. Chronic stress significantly reduced PPI and recognition memory performance and increased serum and hippocampal corticosterone levels. Quetiapine treatment improved PPI and startle responsiveness, restored NOR discrimination index values, and partially attenuated stress-induced corticosterone elevations. Hippocampal BDNF levels were elevated in stressed animals and were modulated toward intermediate levels following quetiapine treatment. These findings indicate that chronic quetiapine administration mitigates behavioral and neuroendocrine alterations induced by prolonged stress in female rats.

The online version contains supplementary material available at 10.1007/s11011-026-01834-8.

## Linked entities

- **Proteins:** BDNF (brain derived neurotrophic factor)
- **Chemicals:** quetiapine (PubChem CID 5002), corticosterone (PubChem CID 5753)

## Full-text entities

- **Genes:** Ntrk2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 25054] {aka RATTRKB1, TRKB1, Tkrb, trk-B, trkB}, Crh (corticotropin releasing hormone) [NCBI Gene 81648] {aka CRF}, Htr2a (5-hydroxytryptamine receptor 2A) [NCBI Gene 29595] {aka 5-HT2A, 5Ht-2}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 24413] {aka GR, Gcr, Grl}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, Slc6a2 (solute carrier family 6 member 2) [NCBI Gene 83511] {aka Net}
- **Diseases:** behavioral impairment (MESH:D001523), neurobehavioral impairments (MESH:D019954), neuroinflammatory (MESH:D000090862), cognitive and sensorimotor disturbances (MESH:D003072), affective disorders (MESH:D019964), UCMS (MESH:D000079225), neuroendocrine disturbances (MESH:D018358), schizophrenia (MESH:D012559), depression (MESH:D003866), impaired hippocampal-dependent learning and memory (MESH:D007859), neuronal atrophy (MESH:D001284), gating deficits (MESH:D009461), major depression (MESH:D003865), HPA axis dysregulation (MESH:D007029), hearing impairment (MESH:D034381), impaired recognition memory (MESH:D008569), anxiety (MESH:D001007), PPI deficits (MESH:C565433), sensory-gating (MESH:D009477), Startle (MESH:D016750), bipolar depression (MESH:D001714), in sensorimotor gating (MESH:D020233), anhedonia (MESH:D059445)
- **Chemicals:** norepinephrine (MESH:D009638), norquetiapine (MESH:C572724), NORT (-), cortisol (MESH:D006854), KCl (MESH:D011189), ethanol (MESH:D000431), oxygen (MESH:D010100), sucrose (MESH:D013395), Quetiapine (MESH:D000069348), CORT (MESH:D003345), Water (MESH:D014867), p-Coumaric acid (MESH:C495469), isoflurane (MESH:D007530), serotonin (MESH:D012701)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13032972/full.md

---
Source: https://tomesphere.com/paper/PMC13032972